Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives

Lingyu Jiang, Jiaping Wei, Junqi Qin, Jing He, Shengjing Liang, Jianwei Huang, Yunzhi Ma, Yifan Zhou, Yonglong Zhong

Open source

DOI
10.3389/fneur.2026.1813230
Published
2026-06-10
Container
Frontiers in Neurology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1813230,
  title = {Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives},
  author = {Lingyu Jiang and Jiaping Wei and Junqi Qin and Jing He and Shengjing Liang and Jianwei Huang and Yunzhi Ma and Yifan Zhou and Yonglong Zhong},
  year = {2026},
  journal = {Frontiers in Neurology},
  doi = {10.3389/fneur.2026.1813230},
  url = {https://doi.org/10.3389/fneur.2026.1813230}
}

RIS

TY  - JOUR
TI  - Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives
AU  - Lingyu Jiang
AU  - Jiaping Wei
AU  - Junqi Qin
AU  - Jing He
AU  - Shengjing Liang
AU  - Jianwei Huang
AU  - Yunzhi Ma
AU  - Yifan Zhou
AU  - Yonglong Zhong
PY  - 2026
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2026.1813230
UR  - https://doi.org/10.3389/fneur.2026.1813230
ER  - 

APA

Jiang, L., Wei, J., Qin, J., He, J., Liang, S., Huang, J., Ma, Y., Zhou, Y., & Zhong, Y. (2026). Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives. Frontiers in Neurology. https://doi.org/10.3389/fneur.2026.1813230

Source records